🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

37+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 17 of 37 recruiting trials for “IgA Nephropathy”

Phase 2Enrolling by InvitationNCT06674577 ↗

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept

👨‍⚕️ Zeeshan Khawaja, Vice President, Clinical Development📍 1 site📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06740526 ↗

Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue

🏥 Otsuka Pharmaceutical Development & Commercialization, Inc.📍 5 sites📅 Started Nov 2024View details ↗
RecruitingNCT06676007 ↗

A Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy

🏥 Sichuan Provincial People's Hospital📍 1 site📅 Started Oct 2024View details ↗
Phase 2RecruitingNCT06670352 ↗

Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients with Primary IgAN

🏥 Haisco Pharmaceutical Group Co., Ltd.📍 2 sites📅 Started Oct 2024View details ↗
Phase 3RecruitingNCT05510323 ↗

Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD

🏥 Air Force Military Medical University, China📍 1 site📅 Started Feb 2024View details ↗
NARecruitingNCT06767592 ↗

A Study of Probiotics in IgA Nephropathy

🏥 University of Leicester📍 1 site📅 Started Oct 2023View details ↗
Phase 1RecruitingNCT05942625 ↗

A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects

🏥 Hansoh BioMedical R&D Company📍 1 site📅 Started May 2023View details ↗
NARecruitingNCT05791162 ↗

Interest of Follicular Helper Lymphocytes / Regulatory Follicular Helper Lymphocytes Ratio in IgA Nephropathy

👨‍⚕️ Melchior Chabannes, MD, Nephrology, CHU Besançon📍 1 site📅 Started May 2023View details ↗
Phase 2RecruitingNCT05775042 ↗

Clinical Study of CM338 in the Treatment of Immunoglobulin A Nephropathy

👨‍⚕️ Jicheng Lv, Peking University First Hospital📍 1 site📅 Started May 2023View details ↗
Phase 4RecruitingNCT04662723 ↗

Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.

👨‍⚕️ Francesco P Schena, Fondazione Schena📍 2 sites📅 Started May 2023View details ↗
RecruitingNCT05434325 ↗

TESTING -ON Post-Trial ObservatioNal Cohort Study

👨‍⚕️ Hong Zhang, Prof, Peking University Institute of Nephrology📍 58 sites📅 Started Dec 2022View details ↗
RecruitingNCT05234463 ↗

Study of the Link Between Complement Activation and IgA Nephropathy Severity

🏥 University Hospital, Strasbourg, France📍 1 site📅 Started May 2022View details ↗
Phase 3RecruitingNCT04557462 ↗

A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

👨‍⚕️ Novartis Pharmaceuticals, Novartis Pharmaceuticals📍 161 sites📅 Started Sep 2021View details ↗
RecruitingNCT04858724 ↗

The Chinese Registry of Prognostic Study of IgA Nephropathy (CRPIGA)

👨‍⚕️ Jingyuan Xie, Ruijin Hospital📍 1 site📅 Started Dec 2020View details ↗
RecruitingNCT05190848 ↗

Correlation of Microbiome and Metabonomics With IgA Nephropathy

👨‍⚕️ Xueqing Yu, Guangdong Provincial People's Hospital📍 5 sites📅 Started May 2020View details ↗
NARecruitingNCT07074951 ↗

Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy

👨‍⚕️ Vladimir Dobronravov, Professor, MD, PhD, DMedSci, St. Petersburg State Pavlov Medical University📍 2 sites📅 Started Mar 2013View details ↗
RecruitingNCT03001947 ↗

IgA Nephropathy Registration Initiative of High Quality (INSIGHT)

🏥 Sun Yat-sen University📍 1 site📅 Started Nov 2012View details ↗
← PreviousPage 2 of 2

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →